NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/28/2025
Back to search
Official data from USPTO
CYPRESS PHARMACEUTICAL, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
08/29/2025
Trademark type
Combined
Nice classes
5
Filing date
05/03/2019
Registration date
10/22/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/28/2025
Last transaction
08/29/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
02/05/1996
First use in commerce
03/04/1996
Drawing code
3
Owner type
16
Owner location
Brentwood, TN
Examiner
EULIN, INGRID
Current location
FILE DESTROYED
Mark description
The mark consists of a rectangular shape with the large, stylized word "CYPRESS" carved out within. The "Y" in "CYPRESS" is made up of a stylized, partially-filled pharmaceutical mortar and pestle device. Underneath "CYPRESS", and in thinner lettering is carved "PHARMACEUTICAL, INC.".
Holders and representatives
Holders
Currax Pharmaceuticals LLC
Currax Pharmaceuticals LLC
Representatives
Andrew N. Spivak MOSAIC LEGAL GROUP, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of painhistamine productioncongestioncoughurinary tract disordersrespiratory ailmentspsychotic conditionshemorrhoidsgastrointestinal disordersspasmspinwormsurinary incontinencenausea; Dietary and nutritional supplements
Publications
History of USPTO decisions and trademark events.
26 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/28/2025
E815
TEAS SECTION 8 & 15 RECEIVED
04/22/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/22/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/27/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/27/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
ALIE
ASSIGNED TO LIE
07/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/20/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2019
GNRT
NON-FINAL ACTION E-MAILED
06/11/2019
CNRT
NON-FINAL ACTION WRITTEN
06/11/2019
DOCK
ASSIGNED TO EXAMINER
06/10/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/24/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/23/2019
NWAP
NEW APPLICATION ENTERED
05/07/2019
Continuous trademark protection
Get notified about every new filing that threatens CYPRESS PHARMACEUTICAL, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.